Essentials of Asthalin HFA Inhaler 200 MD 100 mcg Cipla: what you need to know
Asthalin HFA Inhaler 200 MD 100 mcg Cipla is a prescription medication containing the active substance Salbutamol. It is primarily used as a bronchodilator, which means it helps relax the muscles in the airways, making it easier to breathe. This inhaler is particularly effective for people suffering from asthma or chronic obstructive pulmonary disease (COPD). In addition to its medical use, some athletes explore the potential performance benefits it may offer.
Effectiveness of Asthalin HFA Inhaler 200 MD 100 mcg Cipla in sports
Athletes often consider Asthalin for its ability to enhance breathing efficiency. By relaxing bronchial smooth muscles, it allows more oxygen to flow into the lungs, promoting better oxygen uptake. This can lead to improved strength and endurance during training and competitions. With optimal airflow, athletes may experience quicker recovery times and enhanced performance, making it a useful tool during intense physical sessions. However, it’s essential to note that while it can provide temporary boosts, it should be used responsibly.
Recommended dosages and cycles
For medical purposes, typical dosages range from 100 to 200 mcg via inhalation every 4 to 6 hours. Athletes considering Asthalin must keep in mind dosing guidelines set by their sports authorities to remain compliant with anti-doping regulations. Using the inhaler before training sessions can help manage symptoms and possibly enhance exercise performance. Consulting healthcare professionals for tailored administration plans is always recommended.
Positive aspects of Asthalin HFA Inhaler 200 MD 100 mcg Cipla
Asthalin HFA Inhaler offers several benefits, especially for athletes. Its bronchodilating effects can help improve airflow, enhance oxygen delivery, and increase exercise capacity. Additionally, there are no reported issues with water retention or hepatotoxicity, making it a safe choice for many. By providing immediate relief from breathing difficulties, it allows athletes to train harder and perform better. However, users should be conscious of the side effects, which can include tremors, headaches, palpitations, and a rapid heart rate.
Where to buy Asthalin HFA Inhaler 200 MD 100 mcg Cipla in America?
If you’re looking to buy Asthalin HFA Inhaler 200 MD 100 mcg Cipla, our online store is the perfect option. We offer competitive pricing—only $19.00—allowing you to access this beneficial medication without breaking the bank. With easy navigation and secure payment options, ordering from us is straightforward. Additionally, our commitment to customer satisfaction ensures prompt shipping and high-quality products. Whether you’re an athlete looking to enhance your performance or someone managing a respiratory condition, you can trust our online store for a reliable purchase.
| Active substance |
Salbutamol |
|---|---|
| Water Retention |
None |
| Hepatotoxicity |
None reported |
| Lab Test |
Detection via urine analysis for anti-doping purposes |
| Strength |
100mcg |
| Also known as |
Ventolin |
| Blood pressure |
Can cause transient increases in blood pressure |
| Trade name |
Ventolin, Proventil, Albuterol |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Chemical name |
(RS)-4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol |
| Formula |
C13H21NO3 |
| Substance class |
Beta2-adrenergic agonist |
| Main action |
Bronchodilation |
| Half-life |
4 to 6 hours |
| Dosage (medical) |
2-4 mg orally or 100-200 mcg via inhalation every 4-6 hours |
| Dosage (sports) |
Not applicable as salbutamol is primarily used for medical purposes |
| Effects |
Relaxation of bronchial smooth muscle, increased airflow to the lungs |
| Side effects |
Tremor, headache, palpitations, rapid heart rate |
| Use in sports |
Prohibited above certain thresholds by anti-doping agencies, used for asthma management in athletes with a therapeutic use exemption |
| Manufacturer |
Cipla Ltd. |
| Packing |
1 Inhaler/pack |

Reviews
There are no reviews yet.